BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Szereday L, Meggyes M, Halasz M, Szekeres-Bartho J, Par A, Par G. Immunological changes in different patient populations with chronic hepatitis C virus infection. World J Gastroenterol 2016; 22(20): 4848-4859 [PMID: 27239111 DOI: 10.3748/wjg.v22.i20.4848]
URL: https://www.wjgnet.com/1007-9327/full/v22/i20/4848.htm
Number Citing Articles
1
Marwa K. Ibrahim, Ahmed Khedr, Noha G. Bader El Din, Ahmed Khairy, Mostafa K. El Awady. Increased incidence of cytomegalovirus coinfection in HCV-infected patients with late liver fibrosis is associated with dysregulation of JAK-STAT pathwayScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10604-7
2
Gaitan Fabrice Njiomegnie, Scott A. Read, Nicole Fewings, Jacob George, Fiona McKay, Golo Ahlenstiel. Immunomodulation of the Natural Killer Cell Phenotype and Response during HCV InfectionJournal of Clinical Medicine 2020; 9(4): 1030 doi: 10.3390/jcm9041030
3
Reham Hammad, Mona A Eldosoky, Alshaimaa M Mosaad, Asmaa M El-Nasser, Fatma M Kotb, Salwa I Elshennawy, Noha Abdel-Rahman Eldesoky, Mohamed A Selim, Gina G Naguib, Ossama A Ahmed, Mohamed Alboraie, Reda Badr Aglan. Natural Killer Group 2D Receptor and B1a Cells Crosstalk in Post-Hepatitis C Virus Infection Hepatocellular Carcinoma and CirrhosisJournal of Hepatocellular Carcinoma 2022; : 609 doi: 10.2147/JHC.S360886
4
Xinyu Gu, Qingfei Chu, Xiao Ma, Jing Wang, Chao Chen, Jun Guan, Yanli Ren, Shanshan Wu, Haihong Zhu. New insights into iNKT cells and their roles in liver diseasesFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1035950
5
David F. G. Malone, Sebastian Lunemann, Julia Hengst, Hans-Gustaf Ljunggren, Michael P. Manns, Johan K. Sandberg, Markus Cornberg, Heiner Wedemeyer, Niklas K. Björkström. Cytomegalovirus-Driven Adaptive-Like Natural Killer Cell Expansions Are Unaffected by Concurrent Chronic Hepatitis Virus InfectionsFrontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00525
6
Yang Gao, Narayan Nepal, Shi-Zhu Jin. Toll-like receptors and hepatitis C virus infectionHepatobiliary & Pancreatic Diseases International 2021; 20(6): 521 doi: 10.1016/j.hbpd.2021.07.011
7
Sho Okimoto, Tsuyoshi Kobayashi, Shintaro Kuroda, Kohei Ishiyama, Kentaro Ide, Masahiro Ohira, Hiroyuki Tahara, Seiichi Shimizu, Hiroshi Iwako, Michinori Hamaoka, Naruhiko Honmyo, Megumi Yamaguchi, Hideki Ohdan. Prediction of recurrence following hepatectomy in patients with hepatitis C virus infection‐related hepatocellular carcinoma who achieved a sustained virological responseHepatology Research 2017; 47(11): 1186 doi: 10.1111/hepr.12896
8
Nadia Marascio, Maria Mazzitelli, Grazia Pavia, Aida Giancotti, Giorgio Settimo Barreca, Chiara Costa, Vincenzo Pisani, Giuseppe Greco, Francesca Serapide, Enrico Maria Trecarichi, Francesco Casalinuovo, Maria Carla Liberto, Giovanni Matera, Carlo Torti. Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4Cells 2019; 8(5): 416 doi: 10.3390/cells8050416
9
I. P. Balmasova, M. S. Aristanbekova, E. S. Malova, R. I. Sepiashvili. MECHANISMS OF INTERACTION OF VIRAL CAUSATIVE AGENTS IN PATIENTS CO-INFECTED WITH HUMAN IMMUNODEFICIENCY AND HEPATITIS C VIRUSESJournal of microbiology, epidemiology and immunobiology 2016; 93(5): 101 doi: 10.36233/0372-9311-2016-5-101-109